Amir Nashat Insider Trading $MTCR Metacrine, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Amir Nashat.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Amir Nashat. Amir Nashat is Director in aTYR PHARMA INC ($LIFE) and Director in BIND Therapeutics, Inc ($BIND) and Director in FATE THERAPEUTICS INC ($FATE) and Director in SELECTA BIOSCIENCES INC ($SELB) and Director in Receptos, Inc. ($RCPT) and Director in Syros Pharmaceuticals, Inc. ($SYRS) and Director in Metacrine, Inc. ($MTCR) and Director in Morphic Holding, Inc. ($MORF) and Director in Scholar Rock Holding Corp ($SRRK).
Amir Nashat in Metacrine, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Amir Nashat: Director
Holdings: 214,962 shares
Latest Transaction: Sep 22 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Amir Nashat in Metacrine, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, LIFE, BIND, FATE, MTCR, MORF, RCPT, SRRK, SELB, SYRS
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 22 2020 | MTCR | Metacrine, Inc. | Nashat Amir | Director | Option Exercise | C | 0.00 | 15,118 | 0 | 0 | |
| Sep 22 2020 | MTCR | Metacrine, Inc. | Nashat Amir | Director | Option Exercise | C | 0.00 | 216,106 | 0 | 0 | |
| Sep 22 2020 | MTCR | Metacrine, Inc. | Nashat Amir | Director | Option Exercise | C | 0.00 | 20,585 | 0 | 0 | |
| Sep 22 2020 | MTCR | Metacrine, Inc. | Nashat Amir | Director | Option Exercise | C | 0.00 | 451,666 | 0 | 0 | |
| Sep 22 2020 | MTCR | Metacrine, Inc. | Nashat Amir | Director | Option Exercise | C | 0.00 | 128,201 | 0 | 0 | |
| Sep 22 2020 | MTCR | Metacrine, Inc. | Nashat Amir | Director | Option Exercise | C | 0.00 | 1,832,582 | 0 | 0 | |
| Sep 22 2020 | MTCR | Metacrine, Inc. | Nashat Amir | Director | Buy | C | 0.00 | 15,118 | 0 | 178,942 | 163.8 K to 178.9 K (+9.23 %) |
| Sep 22 2020 | MTCR | Metacrine, Inc. | Nashat Amir | Director | Buy | C | 0.00 | 216,106 | 0 | 2,715,316 | 2.5 M to 2.7 M (+8.65 %) |
| Sep 22 2020 | MTCR | Metacrine, Inc. | Nashat Amir | Director | Buy | C | 0.00 | 20,585 | 0 | 163,824 | 143.2 K to 163.8 K (+14.37 %) |
| Sep 22 2020 | MTCR | Metacrine, Inc. | Nashat Amir | Director | Buy | C | 0.00 | 451,666 | 0 | 2,499,210 | 2 M to 2.5 M (+22.06 %) |
| Sep 22 2020 | MTCR | Metacrine, Inc. | Nashat Amir | Director | Buy | C | 0.00 | 128,201 | 0 | 143,239 | 15 K to 143.2 K (+852.51 %) |
| Sep 22 2020 | MTCR | Metacrine, Inc. | Nashat Amir | Director | Buy | C | 0.00 | 1,832,582 | 0 | 2,047,544 | 215 K to 2 M (+852.51 %) |
| Sep 22 2020 | MTCR | Metacrine, Inc. | Nashat Amir | Director | Buy | P | 13.00 | 15,038 | 195,494 | 15,038 | 0 to 15 K |
| Sep 22 2020 | MTCR | Metacrine, Inc. | Nashat Amir | Director | Buy | P | 13.00 | 214,962 | 2,794,506 | 214,962 | 0 to 215 K |
Page: 1